1. (a) Byrn S R, Pfeiffer R R and Stowell J G 1999 In Solid-State Chemistry of Drugs 2nd ed. (Indiana: SSCI Inc.); (b) Lipinski C 2002 Am. Pharm. Rev. 5 82; (c) Vippagunta S R, Brittain H G and Grant D J W 2001 Adv. Drug Delivery Rev. 48 3; (d) Babu N J and Nangia A 2011 Cryst. Growth Des. 11 2662
2. (a) Yalkowsky S 1999 In Solubility and Solubilization in Aqueous Media (Washington DC: American Chemical Society); (b) Chemburkar S R, Bauer J, Deming K, Spiwek H, Patel K, Morris J, Henry R, Spanton S, Dziki W, Porter W, Quick J, Bauer P, Donaubauer J, Narayanan B A, Soldani M, McFarland D and McFarland K 2000 Org. Process Res. Dev. 4 413; (c) Saharan V A, Kukkar V, Kataria M, Gera M and Choudhury P K 1999 Int. J. Health Res 2 107; (d) Sanphui P, Bolla G, Nangia A and Chernyshev V V 2014 IUCRJ 1 136
3. (a) Berge S M, Bighley L D and Monkhouse D C 1977 J. Pharm. Sci. 66 1; (b) Prohotsky D L and Zhao F 2012 J. Pharm. Sci. 101 1
4. (a) Stahl P H and Wermuth C G 2002 In Handbook of pharmaceutical salts: Properties, selection and use (Weinheim: Wiley-VCH); (b) Serajuddin A T M 2007 Adv. Drug Del. (Rev.) 59 603; (b) Sarveya V, Templeton J F and Benson H A E 2004 J. Pharm. Pharmacol. 56 717; (c) Kim S, Lee H and Kwan E 2008 Clin. Pharmacol. Therap. 83 S59; (d) Davies G 2001 Pharm. J. 266 322; (e) Sarma B, Thakuria R, Nath K and Nangia A 2011 Cryst. Eng. Comm. 13 3232; (f) Bolla G and Nangia A 2012 Cryst. Growth Des. 12 6250
5. (a) Cardew P T and Davey R J 1985 Proc. R. Soc. Lond. A 398 415; (b) Greco K and Bogner R 2012 J. Pharm Sci. 101 2996